Finerenone for Patients With CKD and Type 2 Diabetes
Finerenone reduced the risks of chronic kidney disease (CKD) progression and cardiovascular events among patients with CKD and type 2 diabetes in an international phase 3 trial.
View ArticleTreatment and Outcomes of Inpatient Hypertension Among Adults With Noncardiac...
This cohort study uses data from the electronic health record of patients admitted to Cleveland Clinic Hospitals to assess the outcomes of adults with noncardiac inpatient admissions who were treated...
View Article
More Pages to Explore .....